SLC19A1, a folate-organic phosphate antiporter, serves as the major transporter of cyclic dinucleotides, and its depletion and overexpression affect cyclic dinucleotide uptake and functional responses, which has implications for the immunotherapeutic treatment of cancer via cGAS-STING pathway.36 This evidence concerns the gene STING1 and cancer.